Z
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Price:
10.48
CNY
0.87%
Market Cap:
¥12.6B
Relative Value
The Relative Value of one Zhejiang Hisun Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 10.48 CNY, Zhejiang Hisun Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhejiang Hisun Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhejiang Hisun Pharmaceutical Co Ltd Competitors
Zhejiang Hisun Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
|
12.6B CNY | 1.3 | 23 | 14.6 | 14.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD | 15 | 47.3 | 31.9 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.6B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.5B CHF | 5.7 | 22.9 | 14.1 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.4 | 31.1 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
